Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1751

-0.0042

-0.35%

GBP/USD

1.3189

-0.0057

-0.43%

USD/JPY

112.39

0.2160

0.19%

USD/CHF

0.9792

0.0037

0.38%

EUR/GBP

0.8910

0.0007

0.08%

USD/CAD

1.2540

0.0021

0.16%

NZD/USD

0.7166

-0.0020

-0.28%

EUR/JPY

132.06

-0.2115

-0.16%

EUR/CHF

1.1506

0.0003

0.02%

AcelRx Pharmaceuticals Inc.

NASDAQ: ACRXHealthcare / Medical Appliances & Equipment / USA
1.92-0.21-9.86%Vol 5 291 8291Y Perf -42.54%
Oct 16th, 2017 15:59
BID1.90 ASK1.95
Open2.10 Previous Close2.13
Pre-Market1.90 After-Trading1.90
 -0.05 -2.56%  -0.05 -2.56%
Target Price
4.95 
Analyst Rating
Moderate Buy 2.17
Potencial %
157.81 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
43/25/25 
Value Ranking
 —    -
Insiders Value % 3/6/12M
35/-90/-90 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
21/-92/-92 
Income Ranking
 —    -
Market Cap (mil)87 
Earnings Rating
Buy
Price Range Ratio 52wk %
0.52 
Earnings Date
7th Nov 2017

Today's Price Range

1.902.15

 

52wk Range

1.905.75

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Strong Sell
Performance
1 Month
-38.06%
3 Months
-20.00%
6 Months
-30.18%
1 Year
-42.54%
3 Years
-73.88%
5 Years
-35.79%
Last Quotes
Name / TickerPriceChg.Chg.%
ACRX1.92-0.2100-9.86
AAPL159.882.89001.84
GOOG992.002.32000.23
MSFT77.650.16000.21
XOM82.810.40000.49
WFC53.800.11000.20
JNJ136.12-0.3100-0.23
FB174.520.78000.45
GE23.360.38001.65
JPM97.841.98002.07
...

TickerPriceChg.%52 Week High
DVA56.934.0270.16
FCX15.273.5317.06
WYNN146.813.15150.40
NBL27.902.7642.03
APA42.732.7269.00
MU41.492.7042.07
HES46.042.3365.56
DFS65.352.3074.33
SYF31.502.2138.06
NRG26.622.1526.68
JPM97.842.0797.95
AMAT55.042.0455.09
BWA52.172.0352.71
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.70
Current Ratio 4.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2.80
Leverage Ratio -2.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin13.90
EBIT Margin-235.20
EBITDA Margin-222.50
Pre-tax Profit Margin-496.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 42.26
PS Ratios 7.90
Price to Cash Flow -
Price to Free Cash Flow -3.20
Cash Flow Per Share -0.69
Price to Tangible Book-3.05
Book Value per Share-0.70
Enterprise Value (in ths.)56 306
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-87.67
ROE last 12 Months 560.27
Return on Assets (5Y Avg) -31.25
ROA last 12 Months -50.96
Return on Capital (5Y Avg) -54.42
ROC last 12 Months -27.92
Return on invested Capital Q -
Return on invested Capital Y-90.89
Assets Turnover0.10
Receivables Turnover4.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)12 203
Revenue per Share 0.27
Revenue Growth 3 Years 3.73
Revenue Growth 5 Years 43.38
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2017-0.28-0.29-3.57
Q01 2017-0.28-0.34-21.43
Q04 2016-0.23-0.218.70
Q03 2016-0.24-0.25-4.17
Q02 2016-0.23-0.24-4.35
Q01 2016-0.22-0.220.00
Q04 2015-0.16-0.24-50.00
Q03 2015-0.220.11150.00
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.263.70Positive
12/2017 QR-0.253.85Positive
12/2017 FY-1.13-0.89Negative
12/2018 FY-0.840.00-
Next Report Date7th Nov 2017
Estimated EPS Next Report-0.26
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume5 291 829
Shares Outstanding (in ths.)45 380
Trades Count7 943
Dollar Volume10 187 527
Avg. Volume978 612
Avg. Weekly Volume9 676 751
Avg. Monthly Volume4 231 958
Avg. Quarterly Volume2 340 421

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

47%53%

Bearish Bullish

91%9%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (33.33 %)
3 (60.00 %)
3 (60.00 %)
Moderate Buy
1 (16.67 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
2 (40.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.17
Moderate Buy
1.80
Moderate Buy
1.80

There are no comments yet.

News

x